Shilpa R. Shenoy - Concepedia

Author

Shilpa R. Shenoy

Frederick National Laboratory for Cancer Research

Also Known As

S R Shenoy, Shilpa R Shenoy, Shilpa R. Shenoy, Shilpa Shenoy

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Frederick National Laboratory for Cancer Research Target (United States)Center for Cancer Research National Cancer Institute Science Applications International Corporation (United States)

About

Shilpa R. Shenoy is an author at Frederick National Laboratory for Cancer Research specializing in medicine, biochemistry, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	508
2	Biochemistry	7	7	541
3	Natural Sciences	5	5	346
4	Cell Biology	3	3	69
5	Biomolecular Engineering	2	2	106

Shilpa R. Shenoy

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Broad-Spectrum<i>In Vitro</i>Activity and<i>In Vivo</i>Efficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the Family<i>Coronaviridae</i> Barry R. O’Keefe, Barbara Giomarelli, Dale L. Barnard, Journal of Virology	2009	301
Structures of the Complexes of a Potent Anti-HIV Protein Cyanovirin-N and High Mannose Oligosaccharides Istvan Botos, Barry R. O’Keefe, Shilpa R. Shenoy, Journal of Biological Chemistry	2002	182
Cyanovirin-N Defines a New Class of Antiviral Agent Targeting N-Linked, High-Mannose Glycans in an Oligosaccharide-Specific Manner Anders Bolmstedt, Barry R. O’Keefe, Shilpa R. Shenoy, Molecular Pharmacology	2001	154
Identification of Biologically Active, HIV TAR RNA-Binding Small Molecules Using Small Molecule Microarrays Joanna Sztuba-Solińska, Shilpa R. Shenoy, Peter C. Gareiss, Journal of the American Chemical Society Drug TargetBiologically ActiveMolecular BiologyNucleic Acid Amplification TestHiv-1 Genome	2014	140
Multisite and Multivalent Binding between Cyanovirin-N and Branched Oligomannosides Shilpa R. Shenoy, Laura G. Barrientos, Daniel M. Ratner, Chemistry & Biology Multivalent BindingHeterocyclicBiochemistryLinear Chain Compound	2002	102
Monomerization of Viral Entry Inhibitor Griffithsin Elucidates the Relationship between Multivalent Binding to Carbohydrates and anti-HIV Activity Tinoush Moulaei, Shilpa R. Shenoy, Barbara Giomarelli, Structure Anti-hiv ActivityBiochemistryMedicineGlycobiologyAntiviral Response	2010	93
Selective Interactions of the Human Immunodeficiency Virus-Inactivating Protein Cyanovirin-N with High-Mannose Oligosaccharides on gp120 and Other Glycoproteins Shilpa R. Shenoy, Barry R. O’Keefe, Anders Bolmstedt, Journal of Pharmacology and Experimental Therapeutics	2001	91
Preclinical Manufacture of Anti-HER2 Liposome-Inserting, scFv-PEG-Lipid Conjugate. 2. Conjugate Micelle Identity, Purity, Stability, and Potency Analysis David F. Nellis, Steven L. Giardina, George M. Janini, Biotechnology Progress Proteinlipid InteractionProtein PurificationScfv-peg-lipid ConjugateConjugate LotsBioanalysis	2005	81
Analysis of the Interaction between the HIV-Inactivating Protein Cyanovirin-N and Soluble Forms of the Envelope Glycoproteins gp120 and gp41 Barry R. O’Keefe, Shilpa R. Shenoy, Dong Xie, Molecular Pharmacology	2000	71
Crystallographic, thermodynamic, and molecular modeling studies of the mode of binding of oligosaccharides to the potent antiviral protein griffithsin N.E. Ziolkowska, Shilpa R. Shenoy, Barry R. O’Keefe, Proteins Structure Function and Bioinformatics Bioorganic ChemistryGlycobiologyShorter OligomannosesPolysaccharideProtein Folding	2007	63

Page 1